| Literature DB >> 30157440 |
Sara C Larsen1, Ivo A Hendriks1, David Lyon2, Lars J Jensen2, Michael L Nielsen3.
Abstract
ADP-ribosylation (ADPr) is a reversible posttranslational modification involved in a range of cellular processes. Here, we report system-wide identification of serine ADPr in human cells upon oxidative stress. High-resolution mass spectrometry and unrestricted data processing confirm that serine residues are the major target of ADPr in HeLa cells. Proteome-wide analysis identifies 3,090 serine ADPr sites, with 97% of acceptor sites modulating more than 2-fold upon oxidative stress, while treatment with the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib abrogates this induction. Serine ADPr predominantly targets nuclear proteins, while structural-predictive analyses reveal that serine ADPr preferentially targets disordered protein regions. The identified ADP-ribosylated serines significantly overlap with known phosphorylated serines, and large-scale phosphoproteomics analysis provides evidence for site-specific crosstalk between serine ADPr and phosphorylation. Collectively, we demonstrate that serine ADPr is a widespread modification and a major nuclear signaling response to oxidative stress, with a regulatory scope comparable to other extensive posttranslational modifications.Entities:
Keywords: ADP-ribosylation; ADPr; DNA damage; PARP inhibitor; PTM; mass spectrometry; oxidative stress; phosphorylation; post-translational modification; proteomics; serine ADP-ribosylation
Mesh:
Substances:
Year: 2018 PMID: 30157440 DOI: 10.1016/j.celrep.2018.07.083
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423